Recurrent Miscarriage Tests: What Investigations May Be Recommended?

Recurrent miscarriage can create an understandable desire to test everything possible. The challenge is that broad panels often identify abnormalities that do not actually explain the losses or change treatment.

ASRM’s 2026 recurrent pregnancy loss guidance defines RPL as two or more presumed intrauterine pregnancy losses before 22 completed weeks. Evaluation should be evidence-based and adapted to the pregnancy history, genetic findings, age and clinical context. Even after appropriate testing, some couples will not receive one clear cause.

For a related clinical pathway, review recurrent pregnancy loss investigations.

You may also find fertility specialist useful when planning the next step.

Confirming the Pregnancy-Loss History

Before ordering tests, the clinician reviews how many losses occurred, gestational age, whether pregnancies were confirmed by ultrasound or pathology, whether chromosome testing was performed, and whether there have been live births or ectopic pregnancies.

Recurrent pregnancy loss tests should be selected from this history rather than from a standard internet package.

Genetic Evaluation

Chromosomal abnormalities in the embryo are a major cause of miscarriage and are strongly influenced by maternal age. Testing pregnancy tissue after a loss can sometimes clarify whether an aneuploid pregnancy was responsible.

Parental karyotyping may be appropriate in selected couples, particularly when pregnancy genetic results or the pattern of losses raises concern about a balanced chromosomal rearrangement.

Related guide: sperm DNA fragmentation test.

Uterine Assessment

Structural abnormalities such as a uterine septum, some fibroids, polyps or adhesions may be relevant to pregnancy loss. Ultrasound, saline sonography, HSG, 3D ultrasound or hysteroscopy may be used according to the clinical question.

The presence of an abnormality does not automatically prove causation, so treatment should be matched to evidence and the exact lesion.

Hormonal and Medical Factors

Thyroid disease, diabetes and other medical conditions may be assessed based on history. Antiphospholipid syndrome is an important acquired thrombophilia associated with recurrent pregnancy loss and has specific diagnostic criteria.

Testing every patient for broad inherited thrombophilia, immune markers or multiple unvalidated biomarkers is not supported by evidence.

For additional context, see HSG vs hysteroscopy.

Male Factors and Sperm Testing

Male reproductive history and semen evaluation remain relevant to the couple. AUA/ASRM male-infertility guidance allows sperm DNA fragmentation testing to be considered in couples with recurrent pregnancy loss, although it is not recommended as a universal initial male test.

The result should be interpreted in context because changing a laboratory marker does not necessarily prove improvement in live birth.

Treatments That Should Not Be Used Empirically

ASRM 2026 notes that several empiric approaches have not shown benefit for unexplained RPL, including routine low-dose aspirin, heparin or enoxaparin without an indication, glucocorticoids, intralipids and several immune therapies.

This is important because patients with unexplained losses are particularly vulnerable to expensive treatments promoted as the missing solution.

Recurrent Miscarriage Hyderabad: Building the Work-Up

For recurrent miscarriage Hyderabad evaluation, bring ultrasound reports, discharge summaries, pathology or genetic results from previous losses, medication history and any fertility-treatment records.

A useful consultation should separate tests that are clearly indicated from optional tests with weak evidence and should include a plan for the next pregnancy, not only a list of investigations.

When to Speak With a Fertility Specialist in Hyderabad

A specialist review is useful when symptoms, test results, age, previous treatment or the length of time trying to conceive make the next decision unclear. Bring previous reports and ask what finding is driving the recommendation, what alternatives are reasonable, and how success will be measured.

You can review secondary infertility for more context.

When you are ready for an individual review, book a consultation.

Practical Checklist Before Your Consultation

Before the appointment, use this checklist to turn online research into specific questions. It helps the clinician focus on findings that can change management and reduces the risk of ordering tests or procedures only because they are available.

How many losses occurred and at what gestational ages?
Was chromosome testing performed on pregnancy tissue?
Is uterine imaging complete?
Are antiphospholipid syndrome or other evidence-based medical tests indicated?
Which proposed tests or treatments are optional and which are supported by current RPL guidance?

Bring previous reports, medication lists and procedure records where relevant. Ask for the reasoning behind each recommendation, the alternatives, the expected benefit and the point at which the plan would be reconsidered.

Frequently Asked Questions

1. How many miscarriages are considered recurrent pregnancy loss?

ASRM 2026 identifies RPL as two or more presumed intrauterine pregnancy losses before 22 completed weeks.

2. Should testing start after two miscarriages?

Evaluation can be considered after two losses, with the exact work-up based on age, pregnancy details and clinical judgment.

3. Are chromosome problems a common cause?

Yes. Embryo chromosomal abnormalities are a major cause of miscarriage and become more common with maternal age.

4. Should miscarriage tissue be genetically tested?

It can be useful in selected cases because the result may clarify the cause and guide the need for parental testing.

5. Do both partners need karyotyping?

Not every couple does. It is considered when the loss pattern or pregnancy genetic results suggest a parental rearrangement.

6. What uterine tests are used?

Ultrasound, 3D ultrasound, saline sonography, HSG or hysteroscopy may be chosen according to the suspected problem.

7. Is thyroid testing part of the work-up?

Thyroid evaluation may be appropriate based on clinical history and standard RPL assessment.

8. Should every patient be tested for inherited thrombophilia?

Broad inherited thrombophilia testing is not routinely supported for all recurrent miscarriage patients.

9. What is antiphospholipid syndrome?

It is an autoimmune clotting disorder associated with pregnancy loss and has specific clinical and laboratory diagnostic criteria.

10. Is sperm DNA fragmentation relevant?

It may be considered in RPL according to male-infertility guidance, but it is not a universal answer to recurrent miscarriage.

11. Should aspirin be taken after recurrent miscarriage?

Do not start aspirin without an indication. ASRM does not support routine empiric aspirin for unexplained RPL.

12. Are immune treatments recommended?

Many immune tests and treatments lack evidence for routine use in unexplained recurrent miscarriage.

13. Can IVF prevent miscarriage?

IVF does not prevent every miscarriage. In selected genetic situations, reproductive options may be discussed, but the benefit depends on the diagnosis.

14. What if all tests are normal?

Unexplained RPL is common. Many patients still have a meaningful chance of future live birth with supportive, evidence-based care.

15. What should I bring to an RPL consultation?

Bring records from each pregnancy loss, ultrasound reports, pathology or genetic results and any prior fertility investigations.

Key Takeaway

The best use of information about recurrent miscarriage tests is to improve the next clinical conversation. Use the article to understand the terminology and decision points, then confirm the diagnosis, evidence, risks and treatment options with the fertility team.

Recurrent Miscarriage Tests: Evidence-Based RPL Work-Up